GD2/PSMA Bi-specific CAR-T Cell Therapy
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors
- Status
- RECRUITING
- Phase
- NA
Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for the Treatment of Metastatic/Recurrent Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of TRK-950 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Universal Germline Testing in the Community
- Status
- UNKNOWN
- Phase
- N/A
Artificial Intelligence to Search for Abnormalities in Ambulatory Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
- Status
- RECRUITING
- Phase
- N/A
An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fed Condition
- Status
- COMPLETED
- Phase
- PHASE1
Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fasting Condition
- Status
- COMPLETED
- Phase
- PHASE1
Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
- Status
- RECRUITING
- Phase
- N/A
PhI to Solid Tumors and PhII to Locally Advanced or mTNBC
- Status
- COMPLETED
- Phase
- PHASE1
A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors or Other Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of ASP3082 in Adults With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Camrelizumab Combined With Apatinib Mesylate
- Status
- UNKNOWN
- Phase
- NA
Study to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
SHP2 Inhibitor BBP-398 in Combination With Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer With a KRAS Mutation
- Status
- TERMINATED
- Phase
- PHASE1